# DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY

> **NCT03719612** · PHASE3 · COMPLETED · sponsor: **Lantheus Medical Imaging** · enrollment: 160 (actual)

## Conditions studied

- Cardiac Disease

## Interventions

- **DRUG:** DEFINITY®

## Key facts

- **NCT ID:** NCT03719612
- **Lead sponsor:** Lantheus Medical Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-28
- **Primary completion:** 2020-01-09
- **Final completion:** 2020-01-09
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2021-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03719612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03719612, "DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03719612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
